Health Condition 1: C53- Malignant neoplasm of cervix uteri
Conditions
Interventions
Intervention1: Three dimensional volumetric image based brachytherapy: Brachytherapy is given in volume based method
Control Intervention1: Point A based brachytherapy: Brachytherapy is given in conve
Sponsors
Sri Venkateswara Institute Of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histo-pathologically confirmed carcinoma of uterine cervix cases. 2.Patients with stage IB2 to IVA according to International Federation of Gynecology and Obstetrics(FIGO). 3. Eastern Cooperative Oncology Group (ECOG) performance score of 0-2. 4. Patients who have signed approved informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients previously treated with surgery or chemotherapy or radiotherapy. 2. FIGO stage IA, IB1, IIIC2, IVA with VVF and IVB cervical cancer. 3. Patient of age > 65 years. 4. ECOG performance score 3-4. 5. Patients who are not willing to sign approved informed consent. 5. Pregnant women and lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor response rateTimepoint: 1 month after treatment completion | — |
Secondary
| Measure | Time frame |
|---|---|
| Late toxicitiesTimepoint: 6 months after treatment completion | — |
Countries
India
Contacts
Public ContactDr P Harika Bhavani
Sri Venkateswara Institute Of Medical Sciences
Outcome results
None listed